MICHAEL BIGHAM - 25 Oct 2022 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Role
Exec. Chairman of the Board, Director
Signature
/s/ William M. Haskell, Attorney-in-Fact for Michael Bigham
Issuer symbol
N/A
Transactions as of
25 Oct 2022
Net transactions value
$0
Form type
4
Filing time
27 Oct 2022, 19:00:42 UTC
Previous filing
10 Aug 2022
Next filing
01 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Award $0 +30,000 +2.5% $0.000000 1,237,827 25 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units ("PRSUs") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 25, 2022.